Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tysabri raises alarm bells on drug class.

× No keyword cloud information.

7 in total

1. PML problems loom for Rituxan.

Authors: Malorye Allison
Journal: Nat Biotechnol Date: 2010-02 Impact factor: 54.908

2. First integrin inhibitor since Tysabri nears approval for IBD.

Authors: Cormac Sheridan
Journal: Nat Biotechnol Date: 2014-03 Impact factor: 54.908

Review 3. Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases.

Authors: Mario E G Moral; Teruna J Siahaan
Journal: Curr Top Med Chem Date: 2017 Impact factor: 3.295

Review 4. RNAi-based therapeutic strategies for metabolic disease.

Authors: Michael P Czech; Myriam Aouadi; Gregory J Tesz
Journal: Nat Rev Endocrinol Date: 2011-04-19 Impact factor: 43.330

5. Activated integrin VLA-4 localizes to the lamellipodia and mediates T cell migration on VCAM-1.

Authors: Young-Min Hyun; Hung-Li Chung; James L McGrath; Richard E Waugh; Minsoo Kim
Journal: J Immunol Date: 2009-07-01 Impact factor: 5.422

Review 6. T-cells in human encephalitis.

Authors: Christian G Bien; Jan Bauer
Journal: Neuromolecular Med Date: 2005 Impact factor: 3.843

7. Blockade of alpha4 integrin signaling ameliorates the metabolic consequences of high-fat diet-induced obesity.

Authors: Chloé C Féral; Jaap G Neels; Christiane Kummer; Marina Slepak; Jerrold M Olefsky; Mark H Ginsberg
Journal: Diabetes Date: 2008-04-21 Impact factor: 9.461

7 in total